Compare HUDI & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUDI | POM |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Other Specialty Stores |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 11.3M |
| IPO Year | 2019 | 2021 |
| Metric | HUDI | POM |
|---|---|---|
| Price | $0.95 | $0.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 836.2K | 95.9K |
| Earning Date | 01-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.66 | $0.06 |
| 52 Week High | $5.46 | $6.43 |
| Indicator | HUDI | POM |
|---|---|---|
| Relative Strength Index (RSI) | 56.30 | 51.35 |
| Support Level | $0.90 | $0.17 |
| Resistance Level | $1.33 | $1.15 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 58.95 | 52.84 |
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.